VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2021 | Post-transplant maintenance strategies in AML

Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses post-transplant maintenance strategies for patients with acute myeloid leukemia (AML), in particular highlighting recommendations from the Acute Leukemia Working Party on sorafenib for patients with mutant FLT3. Prof. Nagler also discusses preventative therapy with donor lymphocyte infusion (DLI) and the role of gilteritinib post-transplant. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter